Literature DB >> 16847778

Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.

Cornelia Cudrici1, Teodora Niculescu, Florin Niculescu, Moon L Shin, Horea Rus.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. It is mediated by activated lymphocytes, macrophages, microglia, and complement. In MS, myelin-forming oligodendrocytes (OLGs) are the targets of inflammatory and immune attacks. OLG death by apoptosis or necrosis causes the cell loss seen in MS plaques. Studies of experimental allergic encephalomyelitis (EAE) in caspase 11-deficient mice show that caspase-mediated death of OLGs is critical to demyelination. Complement activation may affect MS pathogenesis through activated terminal complex C5b-9, which promotes demyelination, and through sublytic C5b-9, which protects OLGs from apoptosis. By inducing EAE in C5-deficient mice, we showed that complement C5 promotes axon preservation and new myelin formation, which protect OLGs from apoptosis. These findings indicate that activated complement C5b-9 plays a proinflammatory role in acute MS but may also protect OLGs from death in chronic MS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847778     DOI: 10.1682/jrrd.2004.08.0111

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  24 in total

1.  Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.

Authors:  Ying Wang; Li Guo; Jueqiong Wang; Wei Shi; Zhilun Xia; Bin Li
Journal:  Exp Ther Med       Date:  2019-09-13       Impact factor: 2.447

Review 2.  The chemical neurobiology of carbohydrates.

Authors:  Heather E Murrey; Linda C Hsieh-Wilson
Journal:  Chem Rev       Date:  2008-05-02       Impact factor: 60.622

3.  Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation.

Authors:  Lisha Liu; Wen Qiu; Hui Wang; Yan Li; Jianbo Zhou; Mei Xia; Kai Shan; Rongrong Pang; Ying Zhou; Dan Zhao; Yingwei Wang
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

4.  Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats.

Authors:  Shirin Babri; Faezeh Mehrvash; Gisou Mohaddes; Homeira Hatami; Fariba Mirzaie
Journal:  Adv Pharm Bull       Date:  2015-03-05

5.  Neuroprotection by ulinastatin in experimental autoimmune encephalomyelitis.

Authors:  Yaqing Shu; Yu Yang; Wei Qiu; Zhengqi Lu; Ying Li; Jian Bao; Ming Feng; Xueqiang Hu
Journal:  Neurochem Res       Date:  2011-06-12       Impact factor: 3.996

Review 6.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

Review 7.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

8.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

9.  Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

Authors:  Mahdi Goudarzvand; Mohammad Javan; Javad Mirnajafi-Zadeh; Sabah Mozafari; Taki Tiraihi
Journal:  Cell Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.046

10.  In trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses.

Authors:  Jason A Cascio; Marie-Therese Khairallah; Xiaoxiao Wan; Weirong Chen; Linda M Rowland; Mermagya Dhakal; Mindy M Miller; Habib Zaghouani
Journal:  J Neuroimmunol       Date:  2013-10-05       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.